REM sleep behavior disorder clinical trials
13 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder
- An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
- Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
- Intestinal Immunity in Neurologic Disease
- Natural History Study of Synucleinopathies
- Neuroplasticity in RBD
- Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder
- Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
- INSIGHT: Insomnia, Nightmares, and Sympathetic Hyperactivity Intervention
- North American Prodromal Synucleinopathy Consortium
- MIBG in Aging and Neurologic Disorders
- DaTSCAN Imaging in Aging and Neurodegenerative Disease
- North American Prodromal Synucleinopathy Consortium Stage 2
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “REM sleep behavior disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.